Pharmacokinetic Analysis of High Dose Methotrexate in Pediatric Lymphoblastic Malignancies
NCT02011022
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
291
Enrollment
OTHER
Sponsor class
Conditions
Methotrexate Adverse Reaction
Interventions
DRUG:
3g MTX
DRUG:
5g MTX
Sponsor
The Children's Hospital of Zhejiang University School of Medicine